Pages that link to "Q67294134"
Jump to navigation
Jump to search
The following pages link to CALLA-positive myeloma: an aggressive subtype with poor survival (Q67294134):
Displaying 10 items.
- Current drug therapy for multiple myeloma (Q33611922) (← links)
- Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45RO (UCHL-1) (Q37223279) (← links)
- CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance (Q39649972) (← links)
- Establishment of five human myeloma cell lines (Q42816610) (← links)
- Different reactivity of monoclonal antibodies against common acute lymphoblastic leukaemia antigen (CD10) (Q42840692) (← links)
- Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma (Q42939741) (← links)
- Clinical features of common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma: report of four cases (Q43933637) (← links)
- An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd International Workshop on Human Leucocyte Differentiation Antigens (Q44341483) (← links)
- Multiparameter analyses of normal and malignant human plasma cells: CD38 , CD56 , CD54 , cIg is the common phenotype of myeloma cells (Q67534782) (← links)
- Expression of the neural cell adhesion molecule (CD56) by human myeloma cells (Q67684527) (← links)